prostate cancer and prostatic diseases سال:2017 - دوره:20

Fa | Ar | En


prostate cancer and prostatic diseases
سال:2017 - دوره:20 - شماره:2

Celastrol, an active constituent of the TCM plant Tripterygium wilfordii Hook.f., inhibits prostate cancer bone metastasis - صفحه:156-164 End-of-radiation PSA as a novel prognostic factor in patients undergoing definitive radiation and androgen deprivation therapy for prostate cancer - صفحه:203-209 Erratum: Celastrol, an active constituent of the TCM plant Tripterygium wilfordii Hook.f., inhibits prostate cancer bone metastasis - صفحه:250-250 Establishing the distribution of satellite lesions in intermediate- and high-risk prostate cancer: implications for focused radiotherapy - صفحه:241-248 Formalin disinfection of prostate biopsy needles may reduce post-biopsy infectious complications - صفحه:216-220 Impact of carbohydrate restriction in the context of obesity on prostate tumor growth in the Hi-Myc transgenic mouse model - صفحه:165-171 Is active surveillance a suitable option for African American men with prostate cancer? A systemic literature review - صفحه:127-136 Is prostate cancer stage migration continuing for black men in the PSA era? - صفحه:210-215 Lifestyle guidelines for managing adverse effects on bone health and body composition in men treated with androgen deprivation therapy for prostate cancer: an update - صفحه:137-145 Meta-analysis of metabolic syndrome and prostate cancer - صفحه:146-155 Prognostic value of the new Grade Groups in Prostate Cancer: a multi-institutional European validation study - صفحه:197-202 Radiographic progression with nonrising PSA in metastatic castration-resistant prostate cancer: post hoc analysis of PREVAIL - صفحه:221-227 Reply to 'Non-surgically related causes of erectile dysfunction after bilateral nerve-sparing radical prostatectomy' - صفحه:249-249 TCF7 is suppressed by the androgen receptor via microRNA-1-mediated downregulation and is involved in the development of resistance to androgen deprivation in prostate cancer - صفحه:172-178 The impact of comorbidity and PSA doubling time on the risk of death in men experiencing PSA failure following radiation therapy with or with androgen deprivation therapy for unfavorable-risk prostate cancer - صفحه:234-240 The prostate cancer prevention trial risk calculator 2.0 performs equally for standard biopsy and MRI/US fusion-guided biopsy - صفحه:179-185 Unscreened older men diagnosed with prostate cancer are at increased risk of aggressive disease - صفحه:193-196 Use of the Prostate Health Index for detection of prostate cancer: results from a large academic practice - صفحه:228-233 Utilization of biopsy-based genomic classifier to predict distant metastasis after definitive radiation and short-course ADT for intermediate and high-risk prostate cancer - صفحه:186-192